Cleerly Health uses artificial intelligence technology to help clinicians identify plaque buildup in heart arteries, according to a July 25 company news release. It said it plans to use this financing to expand and provide more clinicians with its AI technology.
The funding round was led by T. Rowe Price Associates, T. Rowe Price Investment Management and Fidelity Management and Research Co. This financing brings Cleerly Health’s total fundraising to $248 million.
